This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Biopolis, S.l.. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Pepa Ortiz Serrano: Innovator in Obesity Treatment
Introduction
Pepa Ortiz Serrano is a notable inventor based in Valencia, Spain. He has made significant contributions to the field of food and pharmaceuticals, particularly in the treatment and prevention of obesity and related diseases. His innovative work has the potential to impact many lives by addressing critical health issues.
Latest Patents
Pepa Ortiz Serrano holds a patent for a strain of subsp. lactis CECT 8145. This invention is aimed at the treatment and/or prevention of excess weight and obesity, along with associated diseases. The patent details the application of this novel strain within the food and pharmaceutical industries. Specifically, it relates to the cell components, metabolites, and secreted molecules of subsp. CECT 8145, which can be incorporated into food and/or pharmaceutical formulations. This innovation targets various health concerns, including metabolic syndrome, hypertension, glycemia, inflammation, type 2 diabetes, cardiovascular diseases, hypercholesterolemia, hormonal alterations, and infertility.
Career Highlights
Pepa Ortiz Serrano is associated with Biopolis, S.L., where he continues to advance his research and innovations. His work is characterized by a commitment to developing solutions that address pressing health challenges.
Collaborations
Pepa collaborates with talented individuals such as Silvia Llopis Pla and Beatriz Casinos Ramo. Their combined expertise enhances the research and development efforts at Biopolis, S.L.
Conclusion
Pepa Ortiz Serrano is a pioneering inventor whose work in obesity treatment through innovative strains of bacteria holds promise for the food and pharmaceutical industries. His contributions are vital in the ongoing battle against obesity and its related health issues.